Concepedia

Camille Duluc

CD

Statistics

Publications

6

Citations

395

H-Index

6

Active since

2015

Affiliations

Inserm(Current)

Université de Limoges

Centre de Recherches en Cancérologie de Toulouse

Centre National de la Recherche Scientifique

Aix-Marseille Université

Camille Duluc is an author at Inserm specializing in medicine, oncology, and pancreatic cancer.

Publications per year

2015–2022

6

Publications

6

Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

Camille Duluc, Siham Moatassim-Billah, Mounira Chalabi‐Dchar et al. · EMBO Molecular Medicine · 2015 · 196 citations · Full text

Medicine, Oncology, Pharmacology +15

Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression

Victoire Gouirand, Tristan Gicquel, Evan C. Lien et al. · The EMBO Journal · 2022 · 70 citations · Full text

Medicine, Biochemistry, Oncology +9

Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16

Mounira Chalabi‐Dchar, Stéphanie Cassant‐Sourdy, Camille Duluc et al. · Gastroenterology · 2015 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +11

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts

Siham Moatassim-Billah, Camille Duluc, Rémi Samain et al. · Oncotarget · 2016 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages

Rémi Samain, Alexia Brunel, Thibault Douché et al. · Cellular and Molecular Gastroenterology and Hepatology · 2021 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 6